Search Results

There are 11415 results for: content related to: Studies on the inactivation of human parvovirus 4

  1. You have free access to this content
    Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions

    FEMS Immunology & Medical Microbiology

    Volume 62, Issue 3, August 2011, Pages: 247–262, Svetoslav N. Slavov, Simone Kashima, Ana Cristina Silva Pinto and Dimas Tadeu Covas

    Version of Record online : 15 JUN 2011, DOI: 10.1111/j.1574-695X.2011.00819.x

  2. Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses


    Volume 47, Issue 10, October 2007, Pages: 1765–1774, Bernhard Mani, Marco Gerber, Patricia Lieby, Nicola Boschetti, Christoph Kempf and Carlos Ros

    Version of Record online : 19 JUL 2007, DOI: 10.1111/j.1537-2995.2007.01393.x

  3. Pathogen inactivation and removal methods for plasma-derived clotting factor concentrates


    Volume 54, Issue 5, May 2014, Pages: 1406–1417, Robert Klamroth, Albrecht Gröner and Toby L. Simon

    Version of Record online : 30 SEP 2013, DOI: 10.1111/trf.12423

  4. Parvoviruses: agents of distinct pathogenic and molecular potential

    FEMS Microbiology Letters

    Volume 46, Issue 4, October 1987, Pages: 433–450, Günter Siegl and Jon-Duri Tratschin

    Version of Record online : 27 MAR 2006, DOI: 10.1111/j.1574-6968.1987.tb02479.x

  5. Fetal infections of hamsters, rats, and mice induced with the minute virus of mice (MVM)


    Volume 4, Issue 1, February 1971, Pages: 43–61, Lawrence Kilham and George Margolis

    Version of Record online : 6 MAY 2005, DOI: 10.1002/tera.1420040108

  6. Parvoviruses and blood transfusion


    Volume 47, Issue 10, October 2007, Pages: 1745–1750, Kevin E. Brown and Peter Simmonds

    Version of Record online : 18 SEP 2007, DOI: 10.1111/j.1537-2995.2007.01459.x

  7. Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples


    Volume 53, Issue 10pt2, October 2013, Pages: 2575–2584, Peter A.C. Maple, Stuart Beard, Ruth P. Parry and Kevin E. Brown

    Version of Record online : 30 MAY 2013, DOI: 10.1111/trf.12278

  8. Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donors

    Journal of Medical Virology

    Volume 84, Issue 10, October 2012, Pages: 1652–1665, Svetoslav Nanev Slavov, Simone Kashima Haddad, Ana Cristina Silva-Pinto, Alberto Anastacio Amarilla, Helda Liz Alfonso, Victor Hugo Aquino and Dimas Tadeu Covas

    Version of Record online : 15 AUG 2012, DOI: 10.1002/jmv.23358

  9. Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter?


    Volume 52, Issue 7, July 2012, Pages: 1398–1403, Eric Delwart

    Version of Record online : 10 JUL 2012, DOI: 10.1111/j.1537-2995.2012.03721.x

  10. Human parvovirus PARV4 in clotting factor VIII concentrates

    Vox Sanguinis

    Volume 93, Issue 4, November 2007, Pages: 341–347, J. F. Fryer, A. R. Hubbard and S. A. Baylis

    Version of Record online : 28 AUG 2007, DOI: 10.1111/j.1423-0410.2007.00979.x

  11. Occurrence of human bocaviruses and parvovirus 4 in solid tissues

    Journal of Medical Virology

    Volume 84, Issue 8, August 2012, Pages: 1267–1273, Päivi Norja, Lea Hedman, Kalle Kantola, Kaisa Kemppainen, Jari Suvilehto, Anne Pitkäranta, Leena-Maija Aaltonen, Mikko Seppänen, Klaus Hedman and Maria Söderlund-Venermo

    Version of Record online : 18 JUN 2012, DOI: 10.1002/jmv.23335

  12. Validation of new real-time polymerase chain reaction assays for detection of hepatitis A virus RNA and parvovirus B19 DNA


    Volume 56, Issue 2, February 2016, Pages: 440–448, Marijke W.A. Molenaar-de Backer, Mirjam de Waal, Margret C. Sjerps and Marco H.G.M. Koppelman

    Version of Record online : 9 SEP 2015, DOI: 10.1111/trf.13334

  13. Inactivation of parvovirus B19 during STIM-4 vapor heat treatment of three coagulation factor concentrates


    Volume 48, Issue 6, June 2008, Pages: 1220–1226, Andreas Berting, Jens Modrof, Ulrike Unger, Matthias Gessner, Andreas Klotz, Gerhard Poelsler and Thomas R. Kreil

    Version of Record online : 10 APR 2008, DOI: 10.1111/j.1537-2995.2008.01662.x

  14. Different susceptibility of B19 virus and mice minute virus to low pH treatment


    Volume 44, Issue 7, July 2004, Pages: 1079–1086, Nicola Boschetti, Isabel Niederhauser, Christoph Kempf, Albert Stühler, Johannes Löwer and Johannes Blümel

    Version of Record online : 28 JUN 2004, DOI: 10.1111/j.1537-2995.2004.03420.x

  15. The genomic and seroprevalence of human bocavirus in healthy Chinese plasma donors and plasma derivatives


    Volume 55, Issue 1, January 2015, Pages: 154–163, Hongxue Li, Miao He, Peibin Zeng, Zhan Gao, Guohui Bian, Chunhui Yang and Wuping Li

    Version of Record online : 22 JUL 2014, DOI: 10.1111/trf.12785

  16. Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates

    Vox Sanguinis

    Volume 100, Issue 4, May 2011, Pages: 351–358, S. Modrow, J. J. Wenzel, S. Schimanski, J. Schwarzbeck, U. Rothe, J. Oldenburg, W. Jilg and A. M. Eis-Hübinger

    Version of Record online : 7 DEC 2010, DOI: 10.1111/j.1423-0410.2010.01445.x

  17. You have free access to this content
    Parvovirus B19 infection in pregnancy: new insights and management

    Prenatal Diagnosis

    Volume 31, Issue 5, May 2011, Pages: 419–425, E. P. de Jong, F. J. Walther, A. C. M. Kroes and D. Oepkes

    Version of Record online : 24 FEB 2011, DOI: 10.1002/pd.2714

  18. Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates


    Volume 52, Issue 7, July 2012, Pages: 1482–1489, Colin P. Sharp, Alice Lail, Sharyne Donfield, Edward D. Gomperts and Peter Simmonds

    Version of Record online : 2 NOV 2011, DOI: 10.1111/j.1537-2995.2011.03420.x

  19. Standardization of nucleic acid amplification technique (NAT)-based assays for different genotypes of parvovirus B19: a meeting summary

    Vox Sanguinis

    Volume 94, Issue 1, January 2008, Pages: 74–80, S. A. Baylis

    Version of Record online : 24 SEP 2007, DOI: 10.1111/j.1423-0410.2007.00992.x

  20. Embryonal carcinoma cells (and their somatic cell hybrids) are resistant to infection by the murine parvovirus MVM, which does infect other teratocarcinoma-derived cell lines

    Journal of Cellular Physiology

    Volume 91, Issue 3, June 1977, Pages: 393–401, Richard A. Miller, David C. Ward and Frank H. Ruddle

    Version of Record online : 4 FEB 2005, DOI: 10.1002/jcp.1040910309